XENETIC BIOSCIENCES, INC. Other Current Liabilities
XENETIC BIOSCIENCES, INC. (XBIO) had Other Current Liabilities of $538.73 thousand as of 2019-09-30, per its 10-Q filed 2019-11-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2019-11-14
- 2019-09-30: Other Liabilities, Current $538.73K.
- 2019-06-30: Other Liabilities, Current $1.29M.
- 2019-03-31: Other Liabilities, Current $965.74K.
- 2018-12-31: Other Liabilities, Current $665.64K; Other Liabilities, Current as first filed $1.61K.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2019-09-30 | $538.73K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $1.29M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $965.74K 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $665.64K 10-Q · filed 2019-11-14 | $1.61K 10-K · filed 2019-03-29 |
| 2017-12-31 | $21.23K 10-K · filed 2019-03-29 | |
| 2017-03-31 | $20.48K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $20.20K 10-K · filed 2018-03-30 | |
| 2016-09-30 | $19.92K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $19.65K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $19.37K 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $19.10K 10-K · filed 2017-03-31 | |
| 2015-09-30 | $33.39K 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $454.99K 10-Q · filed 2015-08-19 | |
| 2015-03-31 | $154.43K 10-Q · filed 2015-05-20 | |
| 2014-12-31 | $41.47K 10-K · filed 2016-03-30 | |
| 2014-09-30 | $42.54K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $44.81K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $34.36K 10-Q · filed 2014-05-20 | |
| 2013-12-31 | $55.27K 10-K · filed 2015-07-20 | |
| 2012-12-31 | $53.66K 10-K · filed 2015-07-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |